18 results
424B3
CHRO
Chromocell Therapeutics Corp.
15 May 24
Prospectus supplement
4:21pm
of intellectual property
44.8 million
Common shares outstanding (as converted)
Value per common share
Illiquidity discount
Minority discount
Fair value
424B3
CHRO
Chromocell Therapeutics Corp.
15 May 24
Prospectus supplement
4:15pm
of intellectual property
44.8 million
Common shares outstanding (as converted)
Value per common share
Illiquidity discount
Minority discount
Fair value
10-Q
2024 Q1
CHRO
Chromocell Therapeutics Corp.
15 May 24
Quarterly report
4:06pm
shares outstanding (as converted)
Value per common share
Illiquidity discount
Minority discount
Fair value of the common stock
After the completion
424B3
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Prospectus supplement
5:49pm
of intellectual property
44.8 million
Common shares outstanding (as converted)
Value per common share
Illiquidity discount
Minority discount
Fair value
424B3
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Prospectus supplement
5:45pm
of intellectual property
44.8 million
Common shares outstanding (as converted)
Value per common share
Illiquidity discount
Minority discount
Fair value
10-K
0sqc0h08kxjoi92p7t
16 Apr 24
Annual report
4:48pm
424B4
of9gta 0z
20 Feb 24
Prospectus supplement with pricing info
5:30pm
424B4
vns pk42vhq
20 Feb 24
Prospectus supplement with pricing info
5:28pm
- Prev
- 1
- Next